US5338723A
(en)
*
|
1989-10-13 |
1994-08-16 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
JPH06500547A
(ja)
*
|
1990-09-14 |
1994-01-20 |
ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング |
ピリジルメチルスルフィニル―1h―ベンゾイミダゾール誘導体のヘリコバクターにより起こされる病気の治療のための使用
|
TW209174B
(no)
*
|
1991-04-19 |
1993-07-11 |
Takeda Pharm Industry Co Ltd |
|
IS3990A
(is)
*
|
1992-04-24 |
1993-10-25 |
Ab Astra |
Aðferð við að blanda saman efni sem hindrar flæðimagasýru og bakteríueyðandi efnis sem brotnar niður í súru umhverfi
|
US5504082A
(en)
*
|
1992-06-01 |
1996-04-02 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Pyridine compound and pharmaceutical compostions
|
PL307026A1
(en)
*
|
1992-07-08 |
1995-05-02 |
Monsanto Co |
Method of producing ppaliative effect in respect to swine gastric ulcers
|
AU674015B2
(en)
*
|
1992-07-28 |
1996-12-05 |
Astra Aktiebolag |
Injection and injection kit containing omeprazole and its analogs
|
ES2087623T3
(es)
*
|
1992-08-21 |
1996-07-16 |
Eisai Co Ltd |
Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon.
|
AU5699594A
(en)
*
|
1992-12-10 |
1994-07-04 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Use of alkylthiopyridines for controlling helicobacter bacteria
|
JPH06298611A
(ja)
*
|
1993-04-16 |
1994-10-25 |
Nippon Chemiphar Co Ltd |
抗菌剤
|
DE59409645D1
(en)
*
|
1993-06-29 |
2001-03-01 |
Byk Gulden Lomberg Chem Fab |
Substituierte arylthioalkylthiopyridine
|
US6489346B1
(en)
*
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US8071128B2
(en)
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
US6861448B2
(en)
*
|
1998-01-14 |
2005-03-01 |
Virtual Drug Development, Inc. |
NAD synthetase inhibitors and uses thereof
|
EP1047692B1
(en)
|
1998-01-14 |
2004-07-21 |
The Uab Research Foundation |
Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof and methods of treating bacterial and microbial infections with these inhibitors
|
FI104384B
(fi)
|
1998-06-05 |
2000-01-14 |
Valmet Corp |
Laitteisto ja menetelmä viiraveden ja tuoremassan sekoittamiseksi viirakaivon jälkeisessä kanavassa
|
CA2419067C
(en)
*
|
2000-08-18 |
2008-12-23 |
Takeda Chemical Industries, Ltd. |
Injectable composition comprising benzimidazole compound and strong alkali
|
CN1243749C
(zh)
|
2001-09-18 |
2006-03-01 |
泽里新药工业株式会社 |
苯并咪唑衍生物
|
US9358214B2
(en)
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
JP2005521662A
(ja)
*
|
2002-01-25 |
2005-07-21 |
サンタラス インコーポレイティッド |
プロトンポンプ阻害剤の経粘膜送達
|
US8367111B2
(en)
*
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
US20040248942A1
(en)
*
|
2003-02-20 |
2004-12-09 |
Bonnie Hepburn |
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
US20050220870A1
(en)
*
|
2003-02-20 |
2005-10-06 |
Bonnie Hepburn |
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
EP1648417A4
(en)
*
|
2003-07-18 |
2010-01-20 |
Santarus Inc |
PHARMACEUTICAL FORMULATION AND METHOD FOR THE TREATMENT OF GASTROINTESTINAL ACIDITY RELATED DISORDERS
|
US8993599B2
(en)
*
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
MXPA06000529A
(es)
*
|
2003-07-18 |
2006-08-11 |
Santarus Inc |
Formulaciones farmaceuticas utiles para inhibir la secrecion de acido y metodos para elaborarlas y utilizarlas.
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
EP1718303A4
(en)
*
|
2004-02-10 |
2010-09-01 |
Santarus Inc |
COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND NON-STEROIDAL ANTI-INFLAMMATORY DRUG
|
CA2561700A1
(en)
*
|
2004-04-16 |
2005-12-15 |
Santarus, Inc. |
Combination of proton pump inhibitor, buffering agent, and prokinetic agent
|
US8906940B2
(en)
*
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8815916B2
(en)
*
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US20060024362A1
(en)
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
US8747895B2
(en)
*
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
US9884014B2
(en)
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
NZ709754A
(en)
|
2004-10-21 |
2017-02-24 |
Adare Pharmaceuticals Inc |
Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
|
US20060105038A1
(en)
*
|
2004-11-12 |
2006-05-18 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions prepared by coacervation
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
CN101309917B
(zh)
*
|
2005-10-06 |
2013-09-11 |
奥斯拜客斯制药有限公司 |
具有增强治疗性质的胃h+,k+-atp酶氘代抑制剂
|
PL2003130T3
(pl)
*
|
2006-03-10 |
2012-04-30 |
Link Genomics Inc |
Nowa pochodna pirydyny o aktywności przeciwko helicobacter pylori
|
CA2654402A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Adel Penhasi |
Multiple unit pharmaceutical formulation
|
CA2654450A1
(en)
*
|
2006-06-05 |
2007-12-13 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted erythromycin analogs
|
US20090092658A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
EP2068841B1
(en)
|
2006-10-05 |
2018-09-26 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
US20080103169A1
(en)
|
2006-10-27 |
2008-05-01 |
The Curators Of The University Of Missouri |
Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
|
KR101353572B1
(ko)
*
|
2009-04-09 |
2014-01-22 |
링크 제노믹스 가부시키가이샤 |
피리딘티오 유도체 및 이를 함유하는 항-헬리코박터피로리 작용을 가지는 의약 조성물
|
KR101765357B1
(ko)
|
2009-12-02 |
2017-08-04 |
아데어 파마수티컬스 에스.알.엘. |
펙소페나딘 마이크로캡슐 및 그것을 함유하는 조성물
|
US20110212171A1
(en)
*
|
2010-01-08 |
2011-09-01 |
Eurand, Inc. |
Taste masked topiramate composition and an orally disintegrating tablet comprising the same
|
EP3288556A4
(en)
|
2015-04-29 |
2018-09-19 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
WO2024075017A1
(en)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition of aortic valve calcification
|